Zaleplon and Azelastine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zaleplon (zaleplon) and Azelastine (azelastine hydrochloride). Common drug interactions include herpes simplex among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Zaleplon and Azelastine. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Zaleplon?

Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,935 Zaleplon users. Check the latest studies of Zaleplon.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.



On Aug, 11, 2026

36 people who take Zaleplon and Azelastine together, and have interactions are studied.

Zaleplon and Azelastine drug interactions.

What are the common drug interactions of Zaleplon and Azelastine, by gender? *:

female:

  1. Herpes simplex (herpes simplex is a common viral infection)
  2. Hospitalisation
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hypertension (high blood pressure)
  5. Hypotension (abnormally low blood pressure)
  6. Immune system disorder
  7. Infection
  8. Influenza
  9. Infusion related reaction
  10. Infusion site erythema (reddening of the skin at infusion site)

male:

  1. Pain
  2. Anxiety
  3. Eye irritation
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hepatic enzyme increased
  6. Hyperlipidaemia (presence of excess lipids in the blood)
  7. Hypersensitivity
  8. Hypokalaemia (low potassium)
  9. Obesity (having too much body fat)
  10. Oropharyngeal pain

What are the common drug interactions of Zaleplon and Azelastine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Agitation (state of anxiety or nervous excitement)
  2. Diarrhoea
  3. Micturition urgency (urgency to pass the urine)
  4. Muscle spasms (muscle contraction)
  5. Nausea (feeling of having an urge to vomit)
  6. Restlessness (not able to rest)

50-59:

  1. Asthenia (weakness)
  2. Death
  3. Eyelid ptosis (falling of the upper or lower eyelid)
  4. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  5. Neuropathy peripheral (surface nerve damage)
  6. Pain
  7. Pancreatic carcinoma (pancreatic cancer)
  8. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  9. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  10. Peripheral nerve injury

60+:

  1. Dizziness
  2. Abdominal discomfort
  3. Oedema peripheral (superficial swelling)
  4. Pneumonia
  5. Sinusitis (inflammation of sinus)
  6. Application site pain
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Fall
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 47.22%
  2. Drowsiness: 4 people, 11.11%
  3. Pain: 3 people, 8.33%
  4. Immunodeficiency Common Variable: 3 people, 8.33%
  5. High Blood Pressure: 3 people, 8.33%
  6. Multiple Allergies (allergy to multiple agents): 2 people, 5.56%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.56%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 5.56%
  9. Asthma: 2 people, 5.56%
  10. Amyotrophic Lateral Sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Zaleplon and Azelastine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zaleplon and Azelastine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zaleplon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azelastine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zaleplon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azelastine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zaleplon and azelastine hydrochloride (the active ingredients of Zaleplon and Azelastine, respectively), and Zaleplon and Azelastine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: